Nervmyo
1 known investors
NervMyo Therapeutics develops a long-acting injectable delivery system combining a FDA-approved biologic (IGF-1) to improve nerve regrowth and prevent muscle wasting following peripheral nerve injury. The company targets nerve injury patients requiring regenerative therapeutics.
BiotechHealthtechMedical Devices
Founders & leadership
E
EricaCEO + Co-Founder
S
SamiCo-Founder